IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $515,226 | +67.0% | 84,325 | +69.5% | 0.00% | 0.0% |
| Q4 2022 | $308,444 | -70.8% | 49,749 | +46.2% | 0.00% | -50.0% |
| Q1 2021 | $1,058,000 | -41.7% | 34,022 | -13.0% | 0.00% | -33.3% |
| Q4 2020 | $1,814,000 | +83.8% | 39,099 | +28.6% | 0.00% | +50.0% |
| Q3 2020 | $987,000 | -67.2% | 30,410 | -72.3% | 0.00% | -60.0% |
| Q2 2020 | $3,011,000 | +49.7% | 109,702 | +63.2% | 0.01% | +66.7% |
| Q1 2020 | $2,012,000 | +69.6% | 67,213 | +56.8% | 0.00% | +200.0% |
| Q4 2019 | $1,186,000 | +158.4% | 42,852 | +70.1% | 0.00% | 0.0% |
| Q3 2019 | $459,000 | +54.5% | 25,197 | -24.9% | 0.00% | – |
| Q4 2018 | $297,000 | -43.4% | 33,573 | -28.1% | 0.00% | -100.0% |
| Q3 2018 | $525,000 | +4.2% | 46,692 | +18.5% | 0.00% | 0.0% |
| Q2 2018 | $504,000 | – | 39,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |